U.S. Physical Therapy Past Earnings Performance
Past criteria checks 0/6
U.S. Physical Therapy's earnings have been declining at an average annual rate of -9.9%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 8% per year. U.S. Physical Therapy's return on equity is 4.7%, and it has net margins of 2.2%.
Key information
-9.9%
Earnings growth rate
-11.8%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 8.0% |
| Return on equity | 4.7% |
| Net Margin | 2.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
Nov 09
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
Aug 07U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
Jul 17U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
Jun 04There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
May 21U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
May 11Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
May 05A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Apr 21Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
Apr 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
Mar 04The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
Dec 23Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
Dec 07U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations
Oct 13Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?
Oct 13U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital
Sep 05Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
Aug 15Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?
Aug 01U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)
Jul 19At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?
May 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price
Apr 16U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet
Apr 01Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital
Mar 04U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook
Feb 23U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit
Feb 12Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?
Jan 24We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt
Dec 20Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching
Dec 05U.S. Physical Therapy: Not The Most Comfortable Prospect
Nov 09Revenue & Expenses Breakdown
How U.S. Physical Therapy makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 639 | 14 | 57 | 0 |
| 30 Jun 24 | 621 | 16 | 54 | 0 |
| 31 Mar 24 | 606 | 18 | 52 | 0 |
| 31 Dec 23 | 599 | 18 | 52 | 0 |
| 30 Sep 23 | 585 | 24 | 50 | 0 |
| 30 Jun 23 | 575 | 26 | 50 | 0 |
| 31 Mar 23 | 564 | 28 | 48 | 0 |
| 31 Dec 22 | 548 | 29 | 46 | 0 |
| 30 Sep 22 | 536 | 39 | 45 | 0 |
| 30 Jun 22 | 522 | 38 | 46 | 0 |
| 31 Mar 22 | 509 | 37 | 47 | 0 |
| 31 Dec 21 | 490 | 31 | 47 | 0 |
| 30 Sep 21 | 477 | 31 | 47 | 0 |
| 30 Jun 21 | 461 | 30 | 44 | 0 |
| 31 Mar 21 | 418 | 32 | 41 | 0 |
| 31 Dec 20 | 418 | 32 | 42 | 0 |
| 30 Sep 20 | 423 | 30 | 43 | 0 |
| 30 Jun 20 | 431 | 31 | 43 | 0 |
| 31 Mar 20 | 473 | 29 | 45 | 0 |
| 31 Dec 19 | 477 | 31 | 45 | 0 |
| 30 Sep 19 | 472 | 30 | 44 | 0 |
| 30 Jun 19 | 468 | 23 | 44 | 0 |
| 31 Mar 19 | 457 | 18 | 42 | 0 |
| 31 Dec 18 | 449 | 17 | 41 | 0 |
| 30 Sep 18 | 442 | 18 | 41 | 0 |
| 30 Jun 18 | 432 | 22 | 39 | 0 |
| 31 Mar 18 | 421 | 21 | 38 | 0 |
| 31 Dec 17 | 410 | 22 | 36 | 0 |
| 30 Sep 17 | 392 | 20 | 34 | 0 |
| 30 Jun 17 | 377 | 20 | 33 | 0 |
| 31 Mar 17 | 363 | 21 | 32 | 0 |
| 31 Dec 16 | 353 | 21 | 32 | 0 |
| 30 Sep 16 | 348 | 20 | 34 | 0 |
| 30 Jun 16 | 344 | 21 | 33 | 0 |
| 31 Mar 16 | 337 | 21 | 32 | 0 |
| 31 Dec 15 | 327 | 21 | 31 | 0 |
| 30 Sep 15 | 320 | 21 | 30 | 0 |
| 30 Jun 15 | 313 | 20 | 31 | 0 |
| 31 Mar 15 | 308 | 20 | 31 | 0 |
| 31 Dec 14 | 301 | 19 | 30 | 0 |
| 30 Sep 14 | 290 | 19 | 29 | 0 |
| 30 Jun 14 | 278 | 18 | 28 | 0 |
| 31 Mar 14 | 267 | 18 | 27 | 0 |
| 31 Dec 13 | 260 | 18 | 26 | 0 |
Quality Earnings: USPH has a large one-off loss of $28.5M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: USPH's current net profit margins (2.2%) are lower than last year (4.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: USPH's earnings have declined by 9.9% per year over the past 5 years.
Accelerating Growth: USPH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: USPH had negative earnings growth (-40.6%) over the past year, making it difficult to compare to the Healthcare industry average (10.4%).
Return on Equity
High ROE: USPH's Return on Equity (4.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:47 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
U.S. Physical Therapy, Inc. is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Alexander Paris | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |